Stifel Says Leidos Is 'The Terminator' Stock During Coronavirus Sell-Off

Government contractor Leidos Holdings Inc LDOS is "The Terminator" of stocks to buy at a time when the market is selling off amid coronavirus concerns, according to Stifel. 

What Happened

Leidos is an information technology company that has heavy exposure to the U.S. defense and health care sectors, according to CNBC.

At a time when investors have outlook-related concerns, Leidos' recent high-profile contract wins, including a $7.7-billion contract with the U.S. Navy, are "not an anomaly," according to the sell-side firm. 

"We see Leidos' as positioned to benefit should the outbreak lead to a broader re-evaluation of public health preparedness given its positioning within the CDC, NIH, and Defense Health Agency," Stifel analysts said.

JPMorgan analysts included Leidos stock in their "COVID-19 Outperformers Basket."

Why It's Important

More than half of Wall Street analysts have a bullish rating on Leidos and none recommend investors sell the stock, according to FactSet, CNBC said. 

While shares are not immune to the broader sell-off, the stock is still up close to 7% for 2020. 

Wells Fargo analysts similarly said Leidos' exposure to the federal government should offer "strong visibility" in terms of accelerating revenue growth for at least the next two years, according to CNBC.

The stock was down 7.25% at $98.01 at the time of publication Monday. 

Related Links:

10 Most Profitable Shorts Since The Coronavirus Sell-Off Ramped Up: Tesla, Amazon And More

Market Bottom Could Be 30% Below Last Month's High, El-Erian Says

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorLong IdeasHealth CareAnalyst RatingsMediaTrading IdeasGeneralCNBCCoronavirusdefenseStifel
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!